Trademark Overview
On Thursday, September 5, 2024, a trademark application was filed for MIVOCELL with the United States Patent and Trademark Office. The USPTO has given the MIVOCELL trademark a serial number of 98734979. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 5, 2024. This trademark is owned by Kyverna Therapeutics, Inc.. The MIVOCELL trademark is filed in the Pharmaceutical Products category with the following description:
Therapeutic pharmaceuticals for the treatment of autoimmune diseases and cancer; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease and cancer; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease and cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances for the treatment of oncological and immune system related diseases and disorders